30th Apr 2026 21:54
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
----------
Brave Bison Group PLC - London-based advertising and communications agency - Pretax profit falls to GBP682,000 in 2025 from GBP2.0 million the year prior, but revenue rises to GBP54.3 million from GBP32.8 million. Bottom line is hurt by jump in administration expenses to GBP33.1 million from GBP19.4 million. Diluted profit per ordinary share is 1.76 pence, down from 3.30p. "Momentum is strong and we are excited for the year ahead," says Chair Oliver Green. Declares dividend for the year of 0.44p per share, up 10% from 0.40p. Expects net revenue and adjusted earnings before interest, tax, depreciation and amortisation to exceed current consensus expectations for FY26. Net revenue in the first quarter of financial 2026 is expected to increase 58% year-on-year.
----------
Novacyt SA - biotechnology group focused on clinical diagnostics - Pretax loss narrows to GBP27.3 million in 2025 from GBP39.4 million the year prior as revenue rises to GBP20.0 million from GBP19.6 million, slightly above market expectations of GBP19.8 million. Underlying revenue grows by 4% or 5% on a constant currency basis. "I am pleased to report a solid set of results, demonstrating sustained growth, ahead of market expectations and setting a solid foundation for future growth," says Chief Executive Lyn Rees. "Our outlook for FY26 looks strong, as we target double digit revenue growth year-on-year and look to continue the path towards Ebitda profitability," Rees adds.
----------
Ferro-Alloy Resources Ltd - developing Balasausqandiq vanadium deposit in southern Kazakhstan - Pretax loss narrows to USD8.4 million in 2025 from USD9.4 million the year prior. Revenue falls to USD4.5 million from USD4.7 million in line with management expectations and the group's strategy for the existing plant to act primarily as a research and development centre for vanadium and carbon black substitute products. Cost of sales decreases to USD6.3 million from USD7.6 million, driven by reductions in the costs of raw materials processed, wages and general operating costs at the existing plant.
----------
Cizzle Biotechnology Holdings PLC - London-based life sciences company - Operating loss before tax narrows to GBP751,000 from GBP2.2 million the year prior. "The outlook for 2026 is encouraging. We anticipate the first commercial revenues from the CIZ1B test in North America following regulatory clearance and launch by our partner BIO. In parallel, we intend to progress licensing partnerships in the UK and in other territories worldwide," company says.
----------
Red Capital PLC - Jersey-based acquisition company - Pretax loss is little changed at GBP224,271 in 2025 from GBP233,650 in 2024. Basic and diluted losses per share are 2.24 pence compared to 2.34p.
----------
Ashington Innovation PLC - special purpose acquisition company - Pretax loss narrows to GBP199,094 in 2025 from GBP268,558 in 2024. There is no other comprehensive income. During the year under review, despite reviewing many potential opportunities, both in the UK and overseas, and entering initial discussions with several of them, says it has not identified any specific acquisition targets into which more detailed negotiations have been entered. Initial discussions continue as the company continues to actively seek a suitable acquisition target, and the intention remains to acquire a controlling interest in target business(es) or company(ies).
----------
SigmaRoc PLC - London-based limestone and minerals company - Reports a solid start to 2026 in the first quarter. Volumes grow modestly year on year absent harsh weather effects causing construction delays in Central and Northern Europe. Total volumes reduce by 3% reflecting the extreme winter conditions. The benefits of mix and pricing resulted in revenue for the period flat year on year at GBP251.5 million. Underlying Ebitda increases 12% on-year to GBP54.9 million, due to effective cost management. Underlying Ebitda margins improve by 250 basis points year on year to 21.8%. Operating profits increases 4% year on year reflecting the continued impact of self-help programmes. Remains confident in SigmaRoc's ability to make further progress in the current year and beyond. The outlook for FY26 remains unchanged.
----------
SIG PLC - Sheffield-based construction specialists - Group like-for-like sales declined 5% to GBP614 million in the quarter to March, reflecting the continued subdued demand backdrop as well as unusually poor weather in the early part of the year. Pricing pressure remains elevated, and year over year pricing was flat in the quarter, despite modest inflation on input costs as expected. Trading started to improve from March, albeit "recent global events have created additional uncertainty over the timing and shape of recovery across the group's markets." Cash flow in the quarter was ahead of plan and the group continues to expect to maintain healthy liquidity throughout the year. First quarter underlying operating profit was lower than the prior year, given the sales decline, and consequently expects H1 profit to be lower than H1 2025. "We are continuing to target a robust performance for the full year 2026, with an increased weighting to the second half," SIG adds. In addition, SIG announce the appointment of Simon Kesterton as chief financial officer with effect from May 1. Kesterton succeeds Ian Ashton who announced his resignation on April 10.
----------
By Jeremy Cutler, Alliance News reporter
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Brave BisonFerro-alloy Resources LimitedCizzle BiotechRed CapitalAshington InnovSigmaroc.SIG